Products - Chronic liver disease | Topic | NICE

Showing 6 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Seladelpar for previously treated primary biliary cholangitis ID6429
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
10 September 2025
Obeticholic acid for treating liver fibrosis in people with steatohepatitis [ID1645]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Maralixibat for treating progressive familial intrahepatic cholestasis [ID3818]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
OrganOx metra for liver transplant [ID5116]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Odevixibat for treating cholestasis and pruritus in Alagille Syndrome [ID6181]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Non-alcoholic fatty liver disease (NAFLD): assessment and management
Status:
In development
Programme:
NICE guideline
Expected publication date:
TBC